The biotechnology sector has boomed since the recession, providing substantial returns for investors in specialist funds exposed to this area.
What to do about Alliance Trust
Hedge fund Elliott Advisors has said it is "surprised and disappointed" by Alliance Trust's response to its proposals for a shake-up of the trust's board.
Navigating 'known unknowns'
Rathbones' multi-asset head David Coombs has said the UK's largest investment trusts must reconsider their branding and investment strategies if they are to attract more interest from fund buyers.
Nick Greenwood, manager of the Miton Worldwide Growth investment trust, discusses a little-heralded UK equity fund that could prosper this year.